The specialized residency in pharmacogenetics is a 12-month, post-graduate program. The purpose of this program is to prepare the resident for a clinical faculty position focused in pharmacogenetics; for practice in healthcare settings, particularly those implementing pharmacogenetics into clinical practice; for further training, and/or a position in industry or the FDA.
The UF Health Personalized Medicine Program launched in June 2012, implementing pharmacogenetics into clinical practice. The pharmacogenetics resident works closely with the residency program director (Kristin Weitzel, PharmD) and plays a central role in the clinical implementation of pharmacogenetic services and the literature evaluation and review process for the Personalized Medicine Program Subcommittee of the Pharmacy and Therapeutics Committee. This committee makes all recommendations regarding clinical implementation of pharmacogenetics, including defining the content of pharmacogenetic electronic health record alerts and drug therapy alternatives. The resident also has an important role in educating clinicians about pharmacogenetics, and clinical responsibilities in ensuring the appropriate use of pharmacogenetic information in patients.
For specific application deadlines please contact: Kristin Weitzel, PharmD, CDE, FAPhA